Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
federal funding
Biotech
HHS division refers Harvard for potential debarment
If Harvard undergoes debarment, the university would be blocked from business relations with any federal agency for a specified time frame.
Eric Sagonowsky
Sep 29, 2025 4:59pm
ARPA-H unveils programs to develop custom gene editing therapies
Sep 26, 2025 10:41am
Alternate history of NIH reveals potential impact of agency cuts
Sep 25, 2025 2:00pm
NIH earmarks $87M for new organoid center
Sep 25, 2025 11:55am
Court finds Trump admin's Harvard funding freeze unlawful
Sep 4, 2025 11:11am
NIH chief orders immediate research review, threatens cuts
Aug 15, 2025 3:53pm
